Celularity Inc.
NASDAQ: CELUW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Joseph Hariri
- Employees
- 120
- Headquarters
- Florham Park, United States
- IPO year
- 2021
- Market cap
- $16.2M
- Website
- https://www.celularity.com
Loading CELUW…
Loading profile data…Frequently asked questions about CELUW
What does Celularity Inc. (CELUW) do?
Celularity Inc., a biotechnology company actively engaged in clinical trials, specializes in developing "off-the-shelf" allogeneic cell therapies sourced from placentas. These innovative treatments are designed to address a range of serious conditions, including various cancers, immune system dysfunctions, and infectious illnesses. The company's...
Where does CELUW trade?
Celularity Inc. (CELUW) trades on the NASDAQ Capital Market.
What sector is CELUW in?
Celularity Inc. (CELUW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Celularity Inc.?
Robert Joseph Hariri is the chief executive officer of Celularity Inc. (CELUW).
Where is Celularity Inc. headquartered?
Celularity Inc. is headquartered in United States.
Does CELUW pay a dividend?
Celularity Inc. (CELUW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CELUW go public?
Celularity Inc. (CELUW) completed its initial public offering in 2021.